Stocks News Feed .com

Stock Market News

Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) will present data across its industry-leading oncology portfolio, covering multiple tumor types and mechanisms of action at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31-June 4, 2019. Data will highlight Pfizer’s cutting-edge approach, expertise in precision medicine and work in immunotherapy combinations, including company-sponsored and collaborative research studies. “The data presented at this year’s ASCO showcase our continued commitment to follow the science, whether it’s expanding our approved medicines for breast and prostate cancers into new populations and lines of t... »

Nortech Systems Reports First Quarter Results

MINNEAPOLIS–(BUSINESS WIRE)–Nortech Systems Incorporated (Nasdaq: NSYS), a leading provider of design and manufacturing solutions for complex electromechanical products, reported net sales of $28.2 million for the first quarter ended March 31, 2019, compared with $26.4 million for the first quarter of 2018. Operating loss for the first quarter of 2019 was $104,000, which compares with an operating loss of $120,000 for the first quarter of 2018. Net loss for the first quarter of 2019 was $363,000, or $0.14 per diluted common share. This compares with a net loss for first quarter of 2018 of $391,000, or $0.14 per diluted common share. The mission of Nortech Systems is to be the mos... »

Spectra7 Announces First Quarter 2019 Financial Results

SAN JOSE, Calif.–(BUSINESS WIRE)–(TSX:SEV) Spectra7 Microsystems Inc. (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, today announced its unaudited financial results for the three month period ended March 31, 2019. A copy of the unaudited consolidated financial statements prepared in accordance with International Financial Reporting Standards and the corresponding management’s discussion and analysis (“MD&A”) for the quarter ended March 31, 2019, can be found under the Company’s profile at Unless otherwise indicated, all amounts in this release are expressed in US dollars. Q... »

Altogen Biosystems Launched GMP Grade Liver Targeted Transfection Reagent for In Vivo Delivery of Biomolecules

AUSTIN, Texas–(BUSINESS WIRE)–First developed in 2012, Altogen’s liver-targeted in vivo transfection reagent has since been successfully used in over 25 research publications for liver tissue and tumor-specific delivery of therapeutic biomolecules such as siRNA, miRNA, mRNA, plasmid DNA, and small proteins. This efficient reagent was selected as the delivery vehicle of choice in several drug development programs; to better accommodate clinical programs, Altogen Biosystems announced the launch of real-time adaptive cGMP manufacturing of liver-targeted in vivo transfection reagent. This new product enables dose, formulation and product changes within a clinical protocol in re... »

Notable Wednesday Option Activity: KEM, ESPR, BAC

Shutterstock photo Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in KEMET Corp. (Symbol: KEM), where a total volume of 3,936 contracts has been traded thus far today, a contract volume which is representative of approximately 393,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 44.4% of KEM’s average daily trading volume over the past month, of 885,895 shares. Especially high volume was seen for the $35 strike call option expiring January 15, 2021 , with 1,103 contracts trading so far today, representing approximately 110,300 underlying shares of KEM. Below... »

Recent Activity